WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORGENESIS INC.Orgenesis Inc. • January 5th, 2024 • Pharmaceutical preparations
This Warrant is issued to Yehuda Nir, or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain Loan Extension Agreement, dated as of January 1, 2024, among Orgenesis Inc., a Nevada corporation (the “Company”), and the Purchaser (the “Loan Extension Agreement”) and is subject to the terms and conditions of the Convertibe Loan Agreement.
Loan Extension Agreement and Warrant grantLoan Extension Agreement • January 5th, 2024 • Orgenesis Inc. • Pharmaceutical preparations
This Loan Extension Agreement (“Extension”) is entered into as of January 1, 2024 (the “Effective Date”), by and between Koligo Therapeutics INC, (“Borrower”), Orgenesis Inc (“ORGS”) and Yehuda Nir (“Lender”). Borrower, ORGS and Lender may each be referred to herein as a “Party,” and collectively as the “Parties”.
Loan Extension Agreement and Warrant grantLoan Extension Agreement and Warrant Grant • January 5th, 2024 • Orgenesis Inc. • Pharmaceutical preparations
This Loan Extension Agreement (“Extension”) is entered into as of January 1, 2024 (the “Effective Date”), by and between Orgenesis LTD, (“Borrower”), Orgenesis Inc (“ORGS”) and Aharon Lukach (“Lender”). Borrower, ORGS and Lender may each be referred to herein as a “Party,” and collectively as the “Parties”.
